Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Colorado, Denver
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Between 18-70 years of age
Have been taking TDF and a ritonavir- or cobicistat-boosted protease inhibitor as part of standard care for treatment of HIV
You may not be if
eGFR \< 30 mL/min
Pregnant or planning pregnancy
Breastfeeding
Any medical, social, or mental-health issue(s) that, in the opinion of the investigators, could interfere with study participation or the study outcomes
Signs or symptoms of decompensated liver disease
Hepatitis B infection
Medications that may cause unwanted drug interactions with ledipasvir/sofosbuvir or emtricitabine/tenofovir alafenamide
Unwillingness or inability to comply with study procedures
